News | Congenital Heart | October 03, 2022

Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there. 

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the cardiac specialists that treat them. 

The space enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. This non-invasive, outpatient test also allows for assessment of blood flow through the heart valves to determine if there is narrowing, backflow, or other issues that prevent optimal function. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there. “Our cardiac teams were involved in the design of the ECHO lab and were able to maximize use of the space,” said Dr. Omosalewa Adewale, medical director of cardiac imaging at Memorial Cardiac and Vascular Institute

Congenital heart disease, cardiomyopathy, infective endocarditis, pericardial disease, and rheumatic heart disease are just a few of the ailments that can be diagnosed through echocardiographic testing. It can also determine how other diseases, including cancer and stroke, have affected the heart’s function. 

Memorial’s cardiac sonographers, cardiology fellowship trainees, and cardiologists all collaborate to interpret imaging tests that influence treatment decisions. 

The Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Cardiovascular care outcomes are regularly reviewed by physician-review panels and nurses to ensure quality assurance that utilizes computerized data collection. 

For more information: mhs.net/services/cardiac-vascular 


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now